There are over 10,000 inherited diseases caused by single genetic mutations, and just a tiny sliver of them have effective treatment options. Investors convinced that gene editingtechnology can solve this problem made CRISPR stocks some of the best performers of the past year, and Crispr Therapeutics AG (NASDAQ: CRSP), in particular, has soared far beyond its peers.
What Makes This CRISPR Stock Better Than the Rest?
Понравилась статья? Подпишитесь на канал, чтобы быть в курсе самых интересных материалов
Подписаться